Therapy Areas: Central Nervous System
15 January 2019 - - US-based RNAi therapeutics company Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) has priced of an underwritten public offering of 5m shares of its common stock at a public offering ...
8 January 2019 - - US-based biopharmaceutical company Sage Therapeutics (NASDAQ: SAGE) has received top-line results from the Phase 3 ROBIN Study, the company said.

This study evaluated t...
7 January 2019 - Sage Therapeutics (Sage) (Nasdaq:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, announced ...
3 January 2019 - - The US Food and Drug Administration has expanded the indication for Sprycel (dasatinib) tablets to include the treatment of pediatric patients one year of age and older wi...
2 January 2019 - - The US Food and Drug Administration granted tentative approval on November 16, 2018 of US-based specialty pharmaceutical company Banner Life Sciences LLC's New Drug Application...
2 January 2019 - Banner Life Sciences LLC , a privately held specialty pharmaceutical company, revealed on Wednesday that it has received tentative approval from the US Food and Drug Administration (F...
Related Headlines